NRC Health Operating Cash Flow
NRC Health (NRC) reported Operating Cash Flow of $8.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- NRC Health net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $1.39M.
- NRC Health net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $7.18M, a 8.03% increase year-over-year.
- NRC Health net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $7.18M, a 12.54% increase year-over-year.
- NRC Health net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $13.76M, a 46.08% increase year-over-year.
- NRC Health net cash provided by (used in) operating activities for fiscal 2025 was $26.45M, a 23.61% decline from fiscal 2024.
- NRC Health net cash provided by (used in) operating activities for fiscal 2024 was $34.63M, a 9.15% decline from fiscal 2023.
- NRC Health net cash provided by (used in) operating activities for fiscal 2023 was $38.11M, a 5.10% increase from fiscal 2022.
- NRC Health net cash provided by (used in) operating activities for fiscal 2022 was $36.27M, a 21.75% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.57M 10-Q · filed 2026-08-04 | $15.74M derived: sum of 3 quarters · filed 2026-08-04 | $29.51M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $7.18M 10-Q · filed 2026-05-06 | $14.36M derived: sum of 2 quarters · filed 2026-05-06 | $28.12M derived: sum of 3 quarters · filed 2026-05-06 | $26.98M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $20.94M derived: sum of 2 quarters · filed 2026-03-05 | $19.80M derived: sum of 3 quarters · filed 2026-08-04 | $26.45M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $13.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $12.63M derived: sum of 2 quarters · filed 2026-08-04 | $19.27M 10-Q · filed 2025-11-07 | $25.65M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $5.51M 10-Q · filed 2026-08-04 | $11.89M derived: sum of 3 quarters · filed 2026-08-04 | $21.31M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $6.65M 10-Q · filed 2026-05-06 | $13.03M derived: sum of 2 quarters · filed 2026-05-06 | $22.45M derived: sum of 3 quarters · filed 2026-05-06 | $29.23M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $15.80M derived: sum of 2 quarters · filed 2026-03-05 | $22.59M derived: sum of 3 quarters · filed 2026-03-05 | $34.63M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $9.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $16.21M derived: sum of 2 quarters · filed 2025-11-07 | $28.25M 10-Q · filed 2025-11-07 | $39.95M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-06-30 | $6.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $18.82M 10-Q · filed 2025-08-08 | $30.53M derived: sum of 3 quarters · filed 2026-03-05 | $40.35M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-03-31 | $12.04M 10-Q · filed 2025-05-09 | $23.75M derived: sum of 2 quarters · filed 2026-03-05 | $33.56M derived: sum of 3 quarters · filed 2026-03-05 | $42.40M derived: sum of 4 quarters · filed 2026-03-05 | |
| 2023-12-31 | $11.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $21.52M derived: sum of 2 quarters · filed 2026-03-05 | $30.36M derived: sum of 3 quarters · filed 2026-03-05 | $38.11M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $9.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $18.65M derived: sum of 2 quarters · filed 2024-11-08 | $26.41M 10-Q · filed 2024-11-08 | $34.51M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-06-30 | $8.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $16.59M 10-Q · filed 2024-08-08 | $24.69M derived: sum of 3 quarters · filed 2025-03-17 | $34.74M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-03-31 | $7.75M 10-Q · filed 2024-05-09 | $15.86M derived: sum of 2 quarters · filed 2025-03-17 | $25.91M derived: sum of 3 quarters · filed 2025-03-17 | $35.73M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2022-12-31 | $8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $18.15M derived: sum of 2 quarters · filed 2025-03-17 | $27.98M derived: sum of 3 quarters · filed 2025-03-17 | $36.27M 10-K · filed 2025-03-17 | |
| 2022-09-30 | $10.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $19.87M derived: sum of 2 quarters · filed 2023-11-09 | $28.16M 10-Q · filed 2023-11-09 | $40.23M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $9.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $18.11M 10-Q · filed 2023-08-04 | $30.18M derived: sum of 3 quarters · filed 2024-02-27 | $38.89M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $8.29M 10-Q · filed 2023-05-05 | $20.36M derived: sum of 2 quarters · filed 2024-02-27 | $29.07M derived: sum of 3 quarters · filed 2024-02-27 | $40.23M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $12.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $20.78M derived: sum of 2 quarters · filed 2024-02-27 | $31.94M derived: sum of 3 quarters · filed 2024-02-27 | $46.34M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $19.86M derived: sum of 2 quarters · filed 2022-11-04 | $34.27M 10-Q · filed 2022-11-04 | $50.49M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2021-06-30 | $11.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $25.57M 10-Q · filed 2022-08-05 | $41.78M derived: sum of 3 quarters · filed 2023-03-03 | $52.30M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2021-03-31 | $14.41M 10-Q · filed 2022-05-06 | $30.63M derived: sum of 2 quarters · filed 2023-03-03 | $41.14M derived: sum of 3 quarters · filed 2023-03-03 | $49.52M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2020-12-31 | $16.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $26.73M derived: sum of 2 quarters · filed 2023-03-03 | $35.11M derived: sum of 3 quarters · filed 2023-03-03 | $40.64M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $10.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $18.90M derived: sum of 2 quarters · filed 2021-11-05 | $24.42M 10-Q · filed 2021-11-05 | $36.36M derived: sum of 4 quarters · filed 2022-03-04 | |
| 2020-06-30 | $8.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $13.90M 10-Q · filed 2021-08-06 | $25.85M derived: sum of 3 quarters · filed 2022-03-04 | $38.71M derived: sum of 4 quarters · filed 2022-03-04 | |
| 2020-03-31 | $5.52M 10-Q · filed 2021-05-07 | $17.47M derived: sum of 2 quarters · filed 2022-03-04 | $30.33M derived: sum of 3 quarters · filed 2022-03-04 | $39.14M derived: sum of 4 quarters · filed 2022-03-04 | |
| 2019-12-31 | $11.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $24.81M derived: sum of 2 quarters · filed 2022-03-04 | $33.62M derived: sum of 3 quarters · filed 2022-03-04 | $40.92M 10-K · filed 2022-03-04 | |
| 2019-09-30 | $12.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $21.67M derived: sum of 2 quarters · filed 2020-11-06 | $28.97M 10-Q · filed 2020-11-06 | $42.89M derived: sum of 4 quarters · filed 2021-03-05 | |
| 2019-06-30 | $8.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $16.11M 10-Q · filed 2020-08-07 | $30.02M derived: sum of 3 quarters · filed 2021-03-05 | $37.56M derived: sum of 4 quarters · filed 2021-03-05 | |
| 2019-03-31 | $7.30M 10-Q · filed 2020-05-08 | $21.21M derived: sum of 2 quarters · filed 2021-03-05 | $28.76M derived: sum of 3 quarters · filed 2021-03-05 | $38.92M derived: sum of 4 quarters · filed 2021-03-05 | |
| 2018-12-31 | $13.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $21.46M derived: sum of 2 quarters · filed 2021-03-05 | $31.62M derived: sum of 3 quarters · filed 2021-03-05 | $39.85M 10-K · filed 2021-03-05 | |
| 2018-09-30 | $7.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $17.71M derived: sum of 2 quarters · filed 2019-11-08 | $25.94M 10-Q · filed 2019-11-08 | $32.55M derived: sum of 4 quarters · filed 2020-03-06 | |
| 2018-06-30 | $10.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $18.39M 10-Q · filed 2019-08-08 | $25.00M derived: sum of 3 quarters · filed 2020-03-06 | $35.86M derived: sum of 4 quarters · filed 2020-03-06 | |
| 2018-03-31 | $8.23M 10-Q · filed 2019-05-08 | $14.84M derived: sum of 2 quarters · filed 2020-03-06 | $25.70M derived: sum of 3 quarters · filed 2020-03-06 | $28.18M derived: sum of 4 quarters · filed 2020-03-06 | |
| 2017-12-31 | $6.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $17.47M derived: sum of 2 quarters · filed 2020-03-06 | $19.95M derived: sum of 3 quarters · filed 2020-03-06 | $28.09M 10-K · filed 2020-03-06 | |
| 2017-09-30 | $10.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $13.34M derived: sum of 2 quarters · filed 2018-11-08 | $21.48M 10-Q · filed 2018-11-08 | $30.30M derived: sum of 4 quarters · filed 2019-03-08 | |
| 2017-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $10.62M 10-Q · filed 2018-08-09 | $19.44M derived: sum of 3 quarters · filed 2019-03-08 | $26.24M derived: sum of 4 quarters · filed 2019-03-08 | |
| 2017-03-31 | $8.14M 10-Q · filed 2018-05-04 | $16.97M derived: sum of 2 quarters · filed 2019-03-08 | $23.76M derived: sum of 3 quarters · filed 2019-03-08 | $30.62M derived: sum of 4 quarters · filed 2019-03-08 | |
| 2016-12-31 | $8.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $15.62M derived: sum of 2 quarters · filed 2019-03-08 | $22.48M derived: sum of 3 quarters · filed 2019-03-08 | $26.84M 10-K · filed 2019-03-08 | |
| 2016-09-30 | $6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $13.65M derived: sum of 2 quarters · filed 2017-11-09 | $18.02M 10-Q · filed 2017-11-09 | $25.13M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | $6.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $11.22M 10-Q · filed 2017-08-04 | $18.34M derived: sum of 3 quarters · filed 2018-03-14 | $23.88M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | $4.37M 10-Q · filed 2017-05-05 | $4.03M 10-Q · filed 2016-05-06 | $11.48M derived: sum of 2 quarters · filed 2018-03-14 | $17.02M derived: sum of 3 quarters · filed 2018-03-14 | $24.68M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $12.65M derived: sum of 2 quarters · filed 2018-03-14 | $20.31M derived: sum of 3 quarters · filed 2018-03-14 | $21.89M 10-K · filed 2018-03-14 | |
| 2015-09-30 | $5.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $13.20M derived: sum of 2 quarters · filed 2016-11-04 | $14.78M 10-Q · filed 2016-11-04 | $20.36M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-06-30 | $7.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $9.23M 10-Q · filed 2016-08-05 | $14.81M derived: sum of 3 quarters · filed 2017-03-03 | $24.06M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-03-31 | $1.58M 10-Q · filed 2016-05-06 | $7.16M derived: sum of 2 quarters · filed 2017-03-03 | $16.40M derived: sum of 3 quarters · filed 2017-03-03 | $22.61M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2014-12-31 | $5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $14.82M derived: sum of 2 quarters · filed 2017-03-03 | $21.03M derived: sum of 3 quarters · filed 2017-03-03 | $26.20M 10-K · filed 2017-03-03 | |
| 2014-09-30 | $9.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $15.45M derived: sum of 2 quarters · filed 2015-11-05 | $20.62M 10-Q · filed 2015-11-05 | $24.59M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | $6.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $11.37M 10-Q · filed 2015-08-06 | $15.35M derived: sum of 3 quarters · filed 2016-03-04 | $24.72M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-03-31 | $5.16M 10-Q · filed 2015-05-08 | $9.14M derived: sum of 2 quarters · filed 2016-03-04 | $18.51M derived: sum of 3 quarters · filed 2016-03-04 | $21.38M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2013-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $13.35M derived: sum of 2 quarters · filed 2016-03-04 | $16.21M derived: sum of 3 quarters · filed 2016-03-04 | $19.32M 10-K · filed 2016-03-04 | |
| 2013-09-30 | $9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $12.24M derived: sum of 2 quarters · filed 2014-11-07 | $15.34M 10-Q · filed 2014-11-07 | $20.88M derived: sum of 4 quarters · filed 2015-03-04 | |
| 2013-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $5.97M 10-Q · filed 2014-08-06 | $11.51M derived: sum of 3 quarters · filed 2015-03-04 | $17.30M derived: sum of 4 quarters · filed 2015-03-04 | |
| 2013-03-31 | $3.10M 10-Q · filed 2014-05-08 | $8.64M derived: sum of 2 quarters · filed 2015-03-04 | $14.43M derived: sum of 3 quarters · filed 2015-03-04 | $20.15M derived: sum of 4 quarters · filed 2015-03-04 | |
| 2012-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $11.33M derived: sum of 2 quarters · filed 2015-03-04 | $17.05M derived: sum of 3 quarters · filed 2015-03-04 | $19.13M 10-K · filed 2015-03-04 | |
| 2012-09-30 | $5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $11.51M derived: sum of 2 quarters · filed 2013-11-07 | $13.59M 10-Q · filed 2013-11-07 | $17.71M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-06-30 | $5.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $7.80M 10-Q · filed 2013-08-08 | $11.92M derived: sum of 3 quarters · filed 2014-03-04 | $18.02M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-03-31 | $2.08M 10-Q · filed 2013-05-08 | $6.20M derived: sum of 2 quarters · filed 2014-03-04 | $12.30M derived: sum of 3 quarters · filed 2014-03-04 | $16.69M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2011-12-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $10.22M derived: sum of 2 quarters · filed 2014-03-04 | $14.61M derived: sum of 3 quarters · filed 2014-03-04 | $18.48M 10-K · filed 2014-03-04 | |
| 2011-09-30 | $6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $10.49M derived: sum of 2 quarters · filed 2012-11-07 | $14.36M 10-Q · filed 2012-11-07 | $16.61M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-06-30 | $4.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $8.26M 10-Q · filed 2012-08-10 | $10.51M derived: sum of 3 quarters · filed 2013-03-01 | $13.71M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-03-31 | $3.88M 10-Q · filed 2012-05-11 | $6.13M derived: sum of 2 quarters · filed 2013-03-01 | $9.32M derived: sum of 3 quarters · filed 2013-03-01 | ||
| 2010-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $5.45M derived: sum of 2 quarters · filed 2013-03-01 | $14.60M 10-K · filed 2013-03-01 | ||
| 2010-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $12.35M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $9.15M 10-Q · filed 2011-08-12 | ||||
| 2009-12-31 | $13.67M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |